BiotechTube

Allogeneic MSC

Phase 2Completed
0 watching 0 views this week⚡ Active
44
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Mild Alzheimer's Disease

Conditions

Mild Alzheimer's Disease

Trial Timeline

Dec 28, 2021 → Sep 29, 2023

NCT ID
NCT05233774

About Allogeneic MSC

Allogeneic MSC is a phase 2 stage product being developed by Longeveron for Mild Alzheimer's Disease. The current trial status is completed. This product is registered under clinical trial identifier NCT05233774. Target conditions include Mild Alzheimer's Disease.

Hype Score Breakdown

Clinical
17
Activity
12
Company
2
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT05233774Phase 2Completed

Competing Products

20 competing products in Mild Alzheimer's Disease

See all competitors
ProductCompanyStageHype Score
Neurosteroid enantiomerOragenicsPhase 2
44
Ranirestat + PlaceboEisaiPhase 2/3
65
Aricept (donepezil hydrochloride) + placeboEisaiApproved
85
Donepezil HClEisaiApproved
85
Donanemab + AducanumabEli LillyPhase 3
77
PPAR alpha + Hydrochlorothiazide + PlaceboEli LillyPhase 2
52
ElagolixAbbVieApproved
85
AZD1446 + PlaceboAstraZenecaPhase 2
52
MEDI1814 for IV injection + MEDI1814 for Subcutaneous Injection + IV Placebo + Placebo for Subcutaneous InjectionAstraZenecaPhase 1
33
Fluticasone propionate (Flovent Diskus) 250 mcg + budesonide 400 mcgAstraZenecaApproved
85
AZD5213 + AZD5213 + AZD5213AstraZenecaPhase 2
52
budesonide/formoterol (Symbicort)AstraZenecaPhase 3
77
MK-8931MerckPhase 1
33
Montelukast to placebo + Placebo to montelukastMerckPre-clinical
23
Verubecestat 12 mg (Parts 1 and 2) + Verubecestat 40 mg (Parts 1 and 2)MerckPhase 3
77
Aliskiren + Hydrochlorothiazide + AmlodipineNovartisApproved
85
LCZ696 + SildenafilNovartisPhase 2
52
QCZ484 + PlaceboNovartisPhase 1
33
Rivastigmine PatchNovartisApproved
85
AFQ056NovartisPhase 1
33

Other Products from Longeveron

Longeveron Mesenchymal Stem Cells (LMSCs)Phase 2
44
Lomecel-B medicinal signaling cellsPhase 2
44
Peripheral Intravenous (IV) infusion of LMSCsPhase 2
44
Longeveron Mesenchymal Stem CellsPhase 1/2
33
Allogeneic Human Mesenchymal Stem Cells (allo-hMSCs) + Placebo + Penicillin/Streptomycin-Free Allogeneic Human Mesenchymal Stem Cells (allo-hMSCs)Phase 1/2
33